Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group. (Q43544947)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2001

Language	Label	Description	Also known as
English	Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.	scientific article published in March 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Michael J. Boyer

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Haryana Dhillon

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

6

object named as

V J Harvey

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

M R Stockler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Jones

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D B Thomson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I N Olver

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A McMullen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V J Gebski

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J A Levi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R J Simes

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

357

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

9258

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

739-745

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of maintenance therapy in disseminated testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of Risk in Metastatic Testis Carcinoma: Impact on Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Bleomycin in germ cell tumor therapy: not all regimens are created equal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamic balanced randomization for clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stopping rules and estimation problems in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-drug therapy in patients with metastatic germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904165-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)04165-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11253966%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43544947&oldid=2248720293"